Results 341 to 350 of about 115,105 (360)

Hydroxychloroquine Retinopathy

American Journal of Ophthalmology, 1991
We analyzed ocular findings from two patients (aged 49 and 60 years) with hydroxychloroquine (Plaquenil, Winthrop Pharmaceuticals, Division of Sterling Drug, Inc., New York, New York) retinopathy. Both patients were treated for systemic lupus erythematosus; one patient was treated with 400 to 800 mg of hydroxychloroquine per day (6.1 to 12.2 mg/kg of ...
A, Weiner, M A, Sandberg, A R, Gaudio, M M, Kini, E L, Berson   +4 more
openaire   +2 more sources

Hydroxychloroquine

Archives of Ophthalmology, 1982
Ninety-nine patients were treated with hydroxychloroquine sulfate for connective tissue diseases during a seven year period. All patients received the medication for at least one year and most were treated with a daily dosage of 400 mg. Four patients experienced toxic effects, but no patient sustained permanent loss of visual acuity.
D R, Tobin, G, Krohel, R I, Rynes
openaire   +2 more sources

Hydroxychloroquine Dose and Risk for Incident Retinopathy

Annals of Internal Medicine, 2023
BACKGROUND Hydroxychloroquine is recommended for all patients with systemic lupus erythematosus and is often used for other inflammatory conditions, but a critical long-term adverse effect is vision-threatening retinopathy.
R. Melles, A. Jorge, M. Marmor, Baijun Zhou, C. Conell, Jingbo Niu, N. McCormick, Yuqing Zhang, Hyon K. Choi   +8 more
semanticscholar   +1 more source

SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.

Current Medicinal Chemistry, 2020
Here we report on the most recent updates on experimental drugs successfully employed in the treatment of the disease caused by SARS CoV-2 coronavirus, also referred to as COVID-19 (COronaVIrus Disease 19).
M. Costanzo, Maria Anna Rachele De Giglio, G. Roviello   +2 more
semanticscholar   +1 more source

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19

Annals of Internal Medicine, 2020
BACKGROUND Hydroxychloroquine and chloroquine have antiviral effects in vitro against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). PURPOSE To summarize evidence about the benefits and harms of hydroxychloroquine or chloroquine for the ...
Adrian V. Hernandez, Y. Roman, V. Pasupuleti, J. J. Barboza, C. M. White   +4 more
semanticscholar   +1 more source

Hydroxychloroquine

Reactions Weekly, 2017
  +7 more sources

Hydroxychloroquine

Reactions Weekly, 2019
  +7 more sources

Hydroxychloroquine

Reactions Weekly, 2022
  +5 more sources

Hydroxychloroquine

Reactions Weekly, 2021
openaire   +2 more sources

[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2020
Jun Chen, Danping Liu, Li Liu, Ping Liu, Qingnian Xu, L. Xia, Y. Ling, Dan Huang, Shuli Song, Dandan Zhang, Zhiping Qian, Tao Li, Yinzhong Shen, Hongzhou Lu   +13 more
semanticscholar   +1 more source